ArticleClinical and translational medicine2019
A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients.
Mehrdokht Mazdeh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.